Meta Biomed Co., Ltd. (KOSDAQ: 059210)

Meta Biomed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14,064	10,796	13,226	10,113	8,639	2,350
Short-Term Investments	-	2,970	4,410	1,957	306.9	1,740
Trading Asset Securities	34,736	3,044	1,505	3,846	12,099	4,007
Cash & Short-Term Investments	48,800	16,810	19,141	15,916	21,044	8,097
Cash Growth	171.43%	-12.18%	20.26%	-24.37%	159.90%	-28.29%
Accounts Receivable	13,121	12,880	12,822	12,409	11,556	15,044
Other Receivables	1,244	1,652	1,682	636.92	572.76	816.61
Receivables	16,865	14,532	14,504	13,046	12,129	15,861
Inventory	14,033	15,402	14,734	15,276	16,963	15,173
Prepaid Expenses	1,624	1,954	1,158	100.45	313.4	377.13
Other Current Assets	4,097	1,227	1,439	1,322	1,673	1,292
Total Current Assets	85,418	49,924	50,976	45,661	52,123	40,800
Property, Plant & Equipment	62,867	59,086	52,123	39,278	42,726	45,591
Long-Term Investments	7,896	7,118	7,687	7,365	6,007	5,778
Goodwill	-	1,008	2,023	524.06	524.06	524.06
Other Intangible Assets	1,851	675.57	688.41	783.26	760.72	770.9
Long-Term Deferred Tax Assets	7,106	7,080	4,783	4,966	2,639	2,002
Long-Term Deferred Charges	-	-	-	70.9	1,185	5,612
Other Long-Term Assets	4,055	1,804	879.89	3,627	1,109	1,380
Total Assets	170,142	130,124	121,072	103,128	107,856	103,292
Accounts Payable	2,107	2,923	2,425	1,922	2,561	3,466
Accrued Expenses	1,771	1,303	910.41	1,121	890.21	973.41
Short-Term Debt	46,063	30,971	31,230	24,830	38,718	30,098
Current Portion of Long-Term Debt	322.6	728.19	948.68	5,532	1,041	100.15
Current Portion of Leases	224.58	246.82	145.81	187.8	312.17	247.33
Current Income Taxes Payable	120.41	6.75	10.1	42.1	86.56	229.37
Other Current Liabilities	21,971	8,293	9,147	4,527	3,801	4,229
Total Current Liabilities	72,579	44,471	44,817	38,161	47,410	39,343
Long-Term Debt	10,498	12,207	11,618	3,842	9,638	7,585
Long-Term Leases	249.65	294.66	128.76	87.6	199.2	436.07
Long-Term Deferred Tax Liabilities	-	-	-	192.08	282.67	282.67
Other Long-Term Liabilities	433	489.03	1,069	551.35	542.24	643.29
Total Liabilities	84,175	57,462	57,633	43,030	58,331	48,430
Common Stock	11,931	11,931	11,931	11,931	11,931	11,931
Additional Paid-In Capital	34,666	34,666	34,455	34,455	34,455	34,455
Retained Earnings	38,197	25,359	15,810	13,640	4,473	8,799
Treasury Stock	-2,842	-2,842	-2,842	-2,778	-2,778	-2,111
Comprehensive Income & Other	1,428	933.39	1,237	1,075	-102.91	192.84
Total Common Equity	83,380	70,048	60,591	58,323	47,978	53,267
Minority Interest	2,587	2,614	2,848	1,775	1,547	1,595
Shareholders' Equity	85,967	72,662	63,439	60,099	49,525	54,862
Total Liabilities & Equity	170,142	130,124	121,072	103,128	107,856	103,292
Total Debt	57,358	44,448	44,072	34,478	49,909	38,467
Net Cash (Debt)	-8,558	-27,638	-24,931	-18,562	-28,864	-30,370
Net Cash Per Share	-239.39	-1208.43	-1089.37	-810.54	-1252.73	-1303.85
Filing Date Shares Outstanding	22.87	22.87	22.87	22.9	22.9	23.27
Total Common Shares Outstanding	22.87	22.87	22.87	22.9	22.9	23.27
Working Capital	12,839	5,452	6,158	7,499	4,712	1,457
Book Value Per Share	3645.66	3062.71	2649.24	2546.74	2095.01	2289.36
Tangible Book Value	81,529	68,364	57,879	57,016	46,693	51,972
Tangible Book Value Per Share	3564.73	2989.08	2530.67	2489.66	2038.91	2233.71
Land	-	6,124	6,768	6,727	8,281	8,704
Buildings	-	34,817	21,322	20,924	22,274	23,256
Machinery	-	47,587	38,737	34,361	36,149	35,938
Construction In Progress	-	1,178	11,993	297.15	463.28	382.07

Source: S&P Capital IQ. Standard template. Financial Sources.